178321-68-1

Basic information

• Product Name: methyl 2-(4-ethynylphenoxy)acetate
• Synonyms: methyl 2-(4-ethynylphenoxy)acetate
• CAS NO: 178321-68-1
• Molecular Weight: 190.199
• Mol File: 178321-68-1.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: methyl 2-(4-ethynylphenoxy)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(4-ethynylphenoxy)acetate(178321-68-1)
• EPA Substance Registry System: methyl 2-(4-ethynylphenoxy)acetate(178321-68-1)

Safety Data

• Hazardous Substances Data: 178321-68-1(Hazardous Substances Data)

Upstream product

• 1878-91-7 (4-bromophenoxy)acetic acid 
• 4841-23-0 (4-bromophenoxy)acetic acid methyl ester 
• 1066-54-2 trimethylsilylacetylene 
• 81720-18-5 methyl 2-(4-iodophenoxy)acetate 
• 540-38-5 p-Iodophenol 
• 67-56-1 methanol 
• 178321-69-2 ethyl 2-(4-(2-(trimethylsilyl)ethynyl)phenoxy)acetate 
• 90794-33-5 4-iodophenoxyacetic acid ethyl ester 

Downstream Products

• 1045859-82-2 C₁₈H₁₆ClN₃O₃ 
• 178321-78-3 tetra(tert-butyl) 2,2',2'',2'''-[[2-(4-aminophenyl)ethylimino]bis(methylene)bis[4-({4-[(methoxycarbonyl)methoxy]phenyl}ethynyl)pyridine-6,2-diyl]bis(methylenenitrilo)]tetrakis(acetate) 

Relevant articles and documents

Super Aryl-Extended Calix[4]pyrroles: Synthesis, Binding Studies, and Attempts To Gain Water Solubility

We describe the synthesis of unprecedented calix[4]pyrrole receptors featuring “super aryl extended” (SAE) cavities. We elaborated the aromatic cavity provided by the αααα-isomer of para-tetraiodo-meso-phenyl calix[4]pyrrole by installing ethynyl-aryl sub

Does targeting Arg98 of FimH lead to high affinity antagonists?

Bacterial resistance has become an important challenge in the treatment of urinary tract infections. The underlying resistance mechanisms can most likely be circumvented with an antiadhesive approach, antagonizing the lectin FimH located at the tip of fim

NOVEL WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES

The invention relates to complexing agents of formula (I): in which A, chrom1, chrom2 and chrom3 are as defined in the description. The invention also relates to the lanthanide complexes obtained from these complexing agents.